Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Cyclacel Boosts Clinical Work With $45M Private Placement

April 28, 2006

By Jennifer Boggs

Cyclacel Boosts Clinical Work With $45M Private Placement

April 28, 2006

By Jennifer Boggs

For Replikins, Replication Data Allow For Predicting Epidemics

April 27, 2006

By Jennifer Boggs

FivePrime, BI Enter Deal In RA Worth Up To $75M

April 27, 2006

By Jennifer Boggs

Financings roundup: Light Sciences Oncology files to raise $86M in IPO

April 27, 2006

By Jennifer Boggs

For Replikins, Replication Data Allow For Predicting Epidemics

April 27, 2006

By Jennifer Boggs

FivePrime, BI Enter Deal In RA Worth Up To $75M

April 27, 2006

By Jennifer Boggs

Light Sciences Oncology Files To Raise $86M In IPO

April 26, 2006

By Jennifer Boggs

Light Sciences Oncology Files To Raise $86M In IPO

April 26, 2006

By Jennifer Boggs

ConjuGon Developing 'Trojan Horse' For Resistant Bacteria

April 25, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...